Up-to-date information from the June 11.09.-14.09.2023 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

The Federal Office for Safety in Health Care has been informed by the Italian authority that, in addition to the provinces already announced, ID WNV NAT testing for donations of blood and blood components has been introduced in the province of Lecce.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that in Hungary, in addition to the regions already announced, confirmed human WNV infections have been recorded in the Baranya region.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that in France, in addition to the regions already announced, human WNV infections have been recorded in the Alpes-Maritimes region.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that confirmed human WNV infections have been recorded in Croatia in the regions of Brod-Posavina, Osijek-Baranja, Vukovar-Srijem and Zagreb.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that confirmed human WNV infections have been recorded in Germany in the Sömmerda region.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that in Spain, in addition to the regions already announced, human WNV infections have been recorded in Barcelona.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that two further autochthonous cases of denue virus infection have been recorded. One case in Nice (Department Alpes Maritimes) with stay in Castallet and La Garde (Department Var) and another case in Perpignan (Department Pyrénées Orientales).

Recall due to nitrosamine contamination above the permitted daily dose